French Biotech Launches €30M IPO to be the First to Treat Rare Disease in Children
By clicking on « Accept all » you consent to the deposit of cookies on your device.
| Cookie | Duration | Description |
|---|---|---|
| cli_user_preference | 12 months | This Cookies is set by GDPR Cookie Consent plugin to save users preference of cookie consent |
| cookielawinfo-checkbox-necessary | 12 months | This cookie is defined by the GDPR Cookie Consent plugin and records the user’s consent to "Necessary" category cookies. |
| cookielawinfo-checkbox-performance | 12 months | This cookie is defined by the GDPR Cookie Consent plugin. The cookie is used to store the user’s consent to "Performance" category cookies. |
| CookieLawInfoConsent | 12 months | This Cookies is set by GDPR Cookie Consent plugin to save users preference of cookie consent |
| pll_language | 12 months | The pll _language cookie is used by Polylang to remember the language selected by the user when he comes back to visit again the website. This cookie is also used to get the language information when not available in another way. |
| viewed_cookie_policy | 12 months | This cookie is defined by the GDPR Cookie Consent plugin and is used to store the user’s acceptance or rejection of cookies. It does not store any personal data. |
| Cookie | Duration | Description |
|---|---|---|
| _ga | 6 months | Records a unique identifier used to generate statistical data on how people use our Website. |
| _ga_VQ7XH9070S | 6 months | Used for reporting and distinguishing a user and to calculate visitor, session and campaign data for site analytics to optimize the services the website can offer. |
| _gat_gtag_UA_28487651_5 | 1 minute | Website ID code for tracking visits This cookie is deleted 1 minute after its creation. |
| _gid | 1 day | Records a unique identifier used to generate statistical data on how people use our Website. This cookie is deleted 1 day after its creation. |